Capitalization 57.15M 62M 4.8B P/E ratio 2023
-14.8x
P/E ratio 2024 * -16.1x
Enterprise value 50.59M 54.89M 4.25B EV / Sales 2023
13x
EV / Sales 2024 * 10.3x
Free-Float
67.76%
Yield 2023 *
-
Yield 2024 * -
More valuation ratios * Estimated data
Dynamic Chart
1 day+1.42%
1 week-1.72%
Current month-1.04%
1 month-0.35%
3 months+5.56%
6 months+20.76%
Current year+18.75%
More quotes
1 week
2.80
Extreme 2.8
2.95
1 month
2.75
Extreme 2.75
2.95
Current year
2.14
Extreme 2.14
2.96
1 year
2.02
Extreme 2.02
2.96
3 years
1.25
Extreme 1.245
3.75
5 years
1.25
Extreme 1.245
3.75
10 years
1.25
Extreme 1.245
3.75
More quotes
Insider TitleAgeSince
Chief Executive Officer - 05-19
Director of Finance/CFO 57 31/01/21
Chief Operating Officer 57 06/08/23
Insider TitleAgeSince
Chairman 53 30/04/16
Director/Board Member 65 31/12/17
Director/Board Member 46 31/03/21
More insiders
Add to a list
Change 5d. change 1-year change 3-years change Capi. ($)
+1.42%-1.72%+11.76% - 62.03M
-0.02%-.--%+21.30%+91.64% 12.57B
+2.41%-5.09%-36.27%-26.41% 7.3B
+0.30%+0.72%-2.63%-58.77% 5.83B
+0.88%+9.72%+7.09%-43.28% 5.15B
-0.33%-1.79%+4.67%+2.34% 5.08B
+1.38%+3.96%+27.85%+6.71% 4.26B
-1.77%-2.16%-15.10%-18.64% 4.22B
+2.28%-4.93%-6.91%-34.32% 3.18B
+0.91%-0.94%-50.61%-89.71% 2.02B
Average +0.76%-0.82%-3.89%-18.94% 4.97B
Weighted average by Cap. +0.62%-0.42%-0.42%+1.30%
See all sector performances

Financials

Ratios2023 2024 *
Net sales 4M 4.34M 336M 5.4M 5.86M 453M
Net income -3.4M -3.69M -285M -3.8M -4.12M -319M
Net Debt -5.8M -6.29M -487M -1.35M -1.46M -113M
More financial data * Estimated data
Logo Bioretec Oy
Bioretec Oy is a Finland-based medical device manufacturer company focusing on the development of strong, safe and reliable bioresorbable implants for pediatric and adult orthopedics. The Company operates as a developer, manufacturer and commercializer of innovative bioresorbable orthopedic implants and implant materials used for the treatment of bone and soft tissue injuries. Bioretec Oy’s existing Activa product portfolio consists of bioabsorbable biopolymer products that are alreadyavailable in the market for applications in pediatrics, trauma surgery as well as sports surgery. Bioretec Oy has one Germany-based subsidiary, BRI.Tech GmbH. The Company’s products are used all over the world.
Employees
0
Calendar
More about the company
Date Price Change Volume
24/07/24 2.850 +1.42% 3 641
23/07/24 2.810 -2.09% 8,391
22/07/24 2.870 -0.35% 8,314
19/07/24 2.880 -1.37% 3,058
18/07/24 2.920 +0.69% 64,238

Delayed Quote Nasdaq Helsinki, July 24, 2024 at 05:00 pm

More quotes
Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
2.810EUR
Average target price
3.850EUR
Spread / Average Target
+37.01%
Consensus

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. BRETEC Stock